Skip to main content

Table 2 Demographic and disease characteristics of participantsa

From: Are Australian clinicians monitoring medication adherence in hematological cancer survivors? Two cross-sectional studies

Characteristic

 

Cancer Registry participants (N = 62)

Treatment Centre participants (N = 98)

Total (N = 160)

Exact p-value

  

n (%)

n (%)

n (%)

 

Sexb

Male

26 (49 %)

57 (58 %)

83 (55 %)

0.307

Female

27 (51 %)

41 (42 %)

68 (45 %)

 

Ageb

18–39 years

1 (2 %)

4 (4 %)

5 (3 %)

0.658

40–49 years

5 (9.4 %)

7 (7 %)

12 (8 %)

 

50–59 years

18 (34 %)

25 (26 %)

43 (28 %)

 

60–69 years

12 (23 %)

31 (32 %)

43 (28 %)

 

70 years and over

17 (32 %)

31 (32 %)

48 (32 %)

 

Cancer typeb

Non-Hodgkin Lymphoma (NHL)

20 (38 %)

18 (18 %)

38 (25 %)

0.051

Acute Leukaemia (AL)

8 (15 %)

11 (11 %)

19 (13 %)

 

Chronic Lymph Leukaemia (CLL)

3 (6 %)

11 (11 %)

14 (9 %)

 

Myeloma

19 (36 %)

39 (40 %)

58 (38 %)

 

Hodgkin Lymphoma (HL)

1 (2 %)

6 (6 %)

7 (5 %)

 

Other

2 (4 %)

13 (13 %)

15 (10 %)

 

Usual residenceb

Urban

30 (57 %)

95 (97 %)

125 (83 %)

<0.0001

Rural

23 (43 %)

3 (3 %)

26 (17 %)

 

Time since diagnosisb

Less than 2 years

-

52 (53 %)

52 (34 %)

<0.0001

2 years and over

53 (100 %)

46 (47 %)

99 (66 %)

 

Marital statusb

Married/living with partner

51 (84 %)

71 (74 %)

122 (78 %)

0.174

Single, never married

10 (16 %)

25 (26 %)

35 (22 %)

 

Educationb

High school or below

28 (48 %)

45 (50 %)

73 (49 %)

0.818

Trade or TAFE

15 (26 %)

26 (29 %)

41 (28 %)

 

University degree

15 (26 %)

19 (21 %)

34 (23 %)

 

Employmentb

Currently employed

23 (38 %)

32 (33 %)

55 (35 %)

0.607

Not employed

38 (62 %)

66 (67 %)

104 (65 %)

 
  1. aParticipants are those who reported currently taking daily cancer-related medications
  2. bTotals may not equal sample size due to missing data values